Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12443094 | 0.82 | LMNA (0.61) | LMNAKMT2ATSHRALDH1A1TP53 | |
| SCHEMBL7121916 | 0.78 | SMN1; SMN2 (0.77) | KMT2ATSHRALDH1A1TP53GAA | |
| SCHEMBL10992690 | 0.77 | SMN1; SMN2 (0.58) | LMNAKMT2ATSHRALDH1A1L3MBTL1 | |
| SCHEMBL10986478 | 0.77 | LMNA (0.55) | LMNAKMT2ATSHRALDH1A1TP53 | |
| SCHEMBL27769249 | 0.76 | EPHX2 (0.66) | LMNAKMT2ATSHRALDH1A1GAA | |
| SCHEMBL6805649 | 0.75 | LMNA (0.56) | LMNAKMT2ATSHRALDH1A1TP53 | |
| SCHEMBL1662914 | 0.75 | GAA (0.59) | KMT2ATSHRALDH1A1TP53GAA | |
| SCHEMBL7445242 | 0.73 | KMT2A (0.59) | LMNAKMT2ATSHRALDH1A1TP53 | |
| SCHEMBL10838817 | 0.73 | SMN1; SMN2 (0.56) | LMNAKMT2ATSHRALDH1A1L3MBTL1 | |
| SCHEMBL20267430 | 0.72 | GAA (0.73) | KMT2ATSHRALDH1A1TP53GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107001744-B | Low molecular weight graft polymers for scale inhibitors | 赫尔克里士有限公司 | 2023-06-16 | — | — | CN | disclosed |